However, there is a paucity of research on the relationship between CCL4 levels and cancer susceptibility, possibly because it is difficult to measure CCL4 levels in the “carcinogenic niche,” which comprises inflammatory cells and their released cytokines in the tumor microenvironment. The gene discussed is CCL4; the disease is neoplasm.